A 2x2 factorial, randomized, open-label trial to evaluate neuromodulators and cough control therapy in patients with refractory or unexplained chronic cough: the FORTITUDE trial protocol
Wafa Hassan, Elena Kum, Ana Oliveira, Ahmed Mohammedalhadi et autres